AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04593290 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oticon Opn S 1 miniRITE hearing aid
Description: Everyone who participates in Part 1 (listening effort testing and cognitive testing) will be invited to participate in Part 2 (hearing aids). It is not a requirement to participate in the administration, 6-week use, and re-testing procedures involved in Part 2 of the study. All cognitively healthy participants will be invited to participate, only MCI patients with a live-in informant will be given this opportunity. After ear measurement and dome and wire length selection, Oticon Opn S 1 miniRITE hearing aid fitting will occur wirelessly using Genie software, followed by hearing aid use instructions. The fitting will use Open domes, the standard NAL-NL2 protocol, and will increase gain seven steps on top of Real Ear Unaided Gain (REUG) from 750 Hz to 6 kHz.
Study NCT04593290 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oticon Opn S 1 miniRITE hearing aid
Description: Everyone who participates in Part 1 (listening effort testing and cognitive testing) will be invited to participate in Part 2 (hearing aids). It is not a requirement to participate in the administration, 6-week use, and re-testing procedures involved in Part 2 of the study. All cognitively healthy participants will be invited to participate, only MCI patients with a live-in informant will be given this opportunity. After ear measurement and dome and wire length selection, Oticon Opn S 1 miniRITE hearing aid fitting will occur wirelessly using Genie software, followed by hearing aid use instructions. The fitting will use Open domes, the standard NAL-NL2 protocol, and will increase gain seven steps on top of Real Ear Unaided Gain (REUG) from 750 Hz to 6 kHz.
Study NCT00537316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to Azathioprine
Description: Placebo to AZA tablet orally every day
Study NCT00537316 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo infusion
Description: Placebo to IFX intravenous (IV) infusion
Study NCT00537316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo infusion
Description: Placebo to IFX intravenous (IV) infusion
Study NCT02709356 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 1-month of 60-40 MCT oil
Description: 1-month supplementation of 30 g MCT oil (60% C10 + 40% C8)/day
Study NCT05113979 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AccuraSee IOPCL with +3.0D add
Description: The IOPCL (intraocular pseudophakic contact lens) consists of a 4.5mm diameter optic. All subjects will receive a +3.0 power regardless of diopter power based on IOL Master. This IOPCL will be coupled to a Bausch and Lomb Model LI61SE or LI61AO intraocular lens to correct residual refractive errors after cataract surgery.
Study NCT01727544 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cartilage cap occlusion surgery
Description: placement of a cartilage cap over the dome of the superior semicircular canal through a combined transmastoid and tegmen mini- craniotomy approach.
Study NCT00421018 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Single corticosteroid inhalers and Singulair
Description: Treatment steps according to preset algorithm
Study NCT00421018 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Single corticosteroid inhalers and Singulair
Description: Treatment steps according to preset algorithm
Study NCT02671084 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sevoflurane
Description: compare effect of sevoflurane when administered before PCI
Study NCT02671084 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sevoflurane
Description: compare effect of sevoflurane when administered before PCI
Study NCT02776891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gallium citrate
Description: Ga-68 citrate will be administered on an outpatient basis at the Center for Molecular and Functional Imaging at China Basin. It will be administered a single time point intravenously prior to PET imaging. The one-time nominal injected dose will be up to 15 mCi containing 10 - 25 μg Ga-68. A simultaneous MRI (PET/MRI) of the head will be used for attenuation correction and anatomic localization of gallium-68 citrate uptake and standardized uptake value (SUV) calculation.
Study NCT02709356 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 1-month of C8 MCT oil
Description: 1-month supplementation of 30 g MCT oil (100% C8)/day (1-month of C8 MCT oïl)
Study NCT01328145 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetylsalicylic acid
Description: 500 mg /day
Study NCT01328145 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Acetylsalicylic acid
Description: 500 mg /day
Study NCT01657539 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Yogurt containing probiotics
Description: patients assigned to this group will use a yogurt containing Bifidobacterium animalis once a day during 14 days before evaluation of the outcomes.
Study NCT01657539 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo yogurt
Description: Patients will use a yogurt without probiotics once a day during 14 days before evaluation of outcomes
Study NCT02370628 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty
Description: The procedure involves percutaneous application of bone cement (polymethylmethacrylate) into collapsed vertebrae, and has been used for treatment of patients with osteoporosis who have severe or prolonged pain following vertebral compression fracture, as well as those with painful, aggressive hemangiomas and osteolytic neoplasms.~In our trial, vertebroplasty shall be performed in two steps:~* Step 1: facet block~* Step 2: cement infusion~Therefore, patients in both arms will undergo Step 1 since our control intervention serves as a routine first part of our active intervention.
Study NCT02370628 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Facet block
Description: A long-acting local anesthetic agent and corticosteroids are injected in the spinal articular facets at the affected level.~All patients will undergo facet block since it serves as a routine first part to percutaneous vertebroplasty.
Study NCT04459481 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bending angle
Description: patients in 70-degree bending angle group are intubated with video stylet at 70-degree bending angle patients in 90-degree bending angle group are intubated with video stylet at 90-degree bending angle
Study NCT02370628 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Facet block
Description: A long-acting local anesthetic agent and corticosteroids are injected in the spinal articular facets at the affected level.~All patients will undergo facet block since it serves as a routine first part to percutaneous vertebroplasty.
Study NCT04793009 — intervention group
Intervention type: DEVICE
Intervention: funnel-shaped, intraperitoneal mesh placement
Description: Implantation of a prophylactic, 3D funnel-shaped, intraperitoneal, non-absorbable and synthetic mesh (Dyna Mesh IPST 2x15x15 cm™ and 3x16x16 cm™, FEG Textiltechnik, Aachen, Germany,)
Study NCT00068367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib hydrochloride
Description: 150 mg per day, daily until disease progression
Study NCT03138031 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol alcohol injection
Description: Day-case procedure; weekly sessions; uses absolute alcohol; under close monitoring; maximum dose of 30 ml; no anesthesia needed and a maximum pain score of 8 limits the procedure. Post-procedure analgesia may be required.
Study NCT01032239 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intrathecal baclofen
Description: ITB test, implant, 6 months follow-up
Study NCT04089943 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Revascularization operation
Description: Participants will be randomized into an endovascular or open bypass procedure.
Study NCT04089943 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control group
Description: Healthy non-PAD participants will be recruited for the study.
Study NCT04509791 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anti-Human Thymocyte Immunoglobulin, Rabbit
Description: MELD - ATG : Minimum effective low dose ant-human thymocyte globulin (rabbit)
Study NCT04509791 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Anti-Human Thymocyte Immunoglobulin, Rabbit
Description: MELD - ATG : Minimum effective low dose ant-human thymocyte globulin (rabbit)
Study NCT04103281 — intervention group
Intervention type: OTHER
Intervention: Sepsis
Description: Sepsis patients in the ICU with a breathing tube
Study NCT03482557 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CESM
Description: Contrast enhanced mammography is a new type of mammogram. It uses contrast material combined with the mammogram to highlight areas that might be breast cancer and that could be missed on the mammogram alone
Study NCT03482557 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI
Description: MRI uses magnets to create a detailed image of the tissues and bones inside of the body
Study NCT01876186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Solifenacin for 12 weeks
Description: Solifenacin 5 mg one a day for 12 weeks
Study NCT01876186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Solifenacin for 24 weeks
Description: Solifenacin 5 mg once a day for 24 weeks
Study NCT02496091 — intervention group
Intervention type: DEVICE
Intervention: ATLANTIS Abutment
Study NCT03261726 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MedEl Test Electrode Placer
Description: This study uses a sterile dummy (i.e., not working) cochlear implant electrode inserted at the time of tumor removal to keep the inner ear from scarring or filling with bone. The significance of this to you is that if you ever become eligible for a cochlear implant sometime after surgery, it may be possible to remove the dummy and insert a functioning cochlear implant.
Study NCT02574052 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: participants' food choices
Description: just recorded the participants' food choices in the school cafeteria
Study NCT02574052 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: menu labelling without nutrition education
Description: The investigators provided every participant with a menu labeling without any interpretation and recorded their dietary selections
Study NCT02574052 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: menu labelling with nutrition education
Description: The investigators not only sent a menu labeling to every participant, but also delivered nutrition education to participants by providing them with nutrition and health knowledge through WeChat daily.
Study NCT01627873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: In group A induction of anesthesia will be performed with Propofol (2mg/kg), Cisatracurium (0.15mg/kg)and continous infusion of Remifentanil (0.15mcg/kg/min).Anesthesia will be maintained by Sevoflurane with oxygen (Fi=40%)and air, with a MAC value to maintain BIS between 40 and 60. Intraoperative analgesia will be obtained with Remifentanil 0.15-0.25mcg/kg/min. Additional boluses of Cisatracurium (0.02mcg/kg)will be administered as needed during surgery. At the beginning of closure of the peritoneum bolus of morphine (0.1mg/kg)and acetaminophen 1g will be administered. Propofol and remifentanil infusions will be interrupted at the end of wound closure.
Study NCT01627873 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: In group B anesthesia will be induced by Propofol (2mg/kg), Fentanyl (2mcg/kg)and Cisatracurium (0.15mg/kg). Anesthesia will be maintained by Sevoflurane, oxygen (Fi=40%) and air and boluses of Fentanyl (50mcg). additional boluses of Cisatracurium (0.02mg/kg)will be administered as needed during surgery. At the beginning of closure of the peritoneum acetaminophen 1g will be administered.
Study NCT03265470 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Patients will receive Loading dose of dexmedetomidine (0.8μg/kg) over 20 minutes, followed by intravenous infusion (0.4μg/kg/h) during intra-operative period till end of procedure.
Study NCT03265470 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: Patients will receive Loading dose of fentanyl (1μg/kg), followed by intravenous infusion (1μg/kg/h) during intra-operative period till end of procedure.
Study NCT04249089 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation video and pamplet
Description: This group will be asked to watch a video and perform relaxation techniques twice a day following surgery
Study NCT04568681 — intervention group
Intervention type: DEVICE
Intervention: Deep brain stimulation (DBS)
Description: Deep brain stimulation is an FDA approved therapy that involves surgical implantation of electrodes in deep brain targets and an implantable pulse generator delivers electrical pulses.
Study NCT01775033 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Description: Develop, implement and evaluate an organized system of regional pediatric emergency care in rural Western Pennsylvania using four pillars: education, community, protocolized triage and transport, and telemedicine.
Study NCT01443806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Description: 75 mg, one time
Study NCT02616692 — intervention group
Intervention type: DRUG
Intervention: Hepatocellular Cancer (HCC) treatments including oral anti-cancer therapy [Nexavar (Sorafenib, BAY43-9006)]
Description: Oral anti-cancer therapy (Sorafenib, an multiple kinase inhibitor), repeated transarterial chemoembolization (TACE) procedures, and hepatic arterial infusion chemotherapy (HAIC)
Study NCT02673164 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: CSCC_ASC
Description: The stem cells will be injected directly into the myocardium using the NOGA XP system (BDS, US)
Study NCT03849443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid Injectable Product (1000 mg intravenous bolus)
Description: Intravenous methods to decrease blood loss
Study NCT03849443 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin C 250 MG Oral Tablet
Description: Oral method of placebo
Study NCT02673164 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: CSCC_ASC
Description: The stem cells will be injected directly into the myocardium using the NOGA XP system (BDS, US)
Study NCT03849443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin C 250 MG Oral Tablet
Description: Oral method of placebo
Study NCT03849443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid 650Mg Tablet
Description: Oral method of treatment group
Study NCT03036579 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Celtra Duo
Description: Full ceramic crowns will be made from the high strength ceramic, Celtra Duo.
Study NCT01820871 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-Management Using Smartphone Application for Type2 DM
Study NCT00287196 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: 48 Gy reference dose in 20 fractions at 5 fractions per week, with a maximum overall treatment time of 30 days.
Study NCT00287196 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy
Description: 48 Gy reference dose in 20 fractions at 5 fractions per week, with a maximum overall treatment time of 30 days.
Study NCT02857400 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: current standard of care
Description: connection documentation faxed to GP (General practitioner) on the day of patient's discharge
Study NCT02857400 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CREDO standard of care
Description: organized consultation return home between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP
Study NCT01471340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mometasone Furoate/Formoterol MDI 100/5 mcg
Description: two inhalations BID
Study NCT01471340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mometasone Furoate/Formoterol MDI 200/5 mcg
Description: two inhalations BID
Study NCT01471340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone Furoate MDI 100 mcg
Description: two inhalations BID
Study NCT01471340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone Furoate MDI 200 mcg
Description: two inhalations BID
Study NCT01471340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI
Description: use as needed for asthma symptoms
Study NCT01471340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI
Description: use as needed for asthma symptoms
Study NCT01471340 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone/prednisolone
Description: Oral prednisone/prednisolone used only as an emergency rescue medication at the discretion of the investigator
Study NCT01471340 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone/prednisolone
Description: Oral prednisone/prednisolone used only as an emergency rescue medication at the discretion of the investigator
Study NCT03341442 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: No hip precautions
Description: No hip precautions practiced after THA surgery
Study NCT01813253 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Irinotecan
Description: 150 mg/m2 IV once every 2 weeks until progression or unacceptable toxicity develops
Study NCT01813253 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: 150 mg/m2 IV once every 2 weeks until progression or unacceptable toxicity develops
Study NCT04143737 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Healthy lifestyle intervention
Description: 38 women participated in the intervention group which was located in a community center in Zur-Baher neighborhood. The intervention consisted of 20 weekly sessions on nutrition, physical activity, stress management skills, and self-monitoring. All taught by professional facilitators (nutritionists, exercise trainers, health coaches, and psychotherapists). Baseline data was collected
Study NCT01813253 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nimotuzumab
Description: 400mg IV once weekly until progression or unacceptable toxicity develops
Study NCT00618553 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: Questionnaire regarding quality-of-life that lasts about 30 minutes.
Study NCT00618553 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation
Description: Rehabilitation treatment given over about 3-4 weeks.
Study NCT01953588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fulvestrant
Description: Fulvestrant 500 mg IM
Study NCT01953588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: anastrozole
Description: Anastrozole 1 mg oral tablet
Study NCT05304793 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive usual management of dyspnea
Study NCT05304793 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy
Description: Receive TAB treatment
Study NCT05304793 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05304793 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT02754674 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: type of anterior cruciate ligament reconstruction
Description: comparison of different types of anterior cruciate ligament reconstruction. transportal technique is double bundle graft using flexible reamer, outside-in technique is single bundle graft with remnant preservation
Study NCT03319342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention
Description: Perform acts of kindness to others
Study NCT03319342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention
Description: Perform acts of kindness to self
Study NCT03319342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention
Description: Perform self-kindness meditation
Study NCT03319342 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Intervention
Description: Keep track of daily activities
Study NCT03319342 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03319342 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT02797457 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Bilateral allograft of the hands and forearms.
Description: Bilateral allograft of the hands and forearms.
Study NCT01820871 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: self-management using booklet for management type 2 DM
Study NCT03387098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aldoxorubicin HCl
Description: Aldoxorubicin hydrochloride